A Phase 1, Single-Center, Randomized, Placebo-Controlled, Ascending Single-Dose Study of the Pharmacokinetics, Safety, and Tolerability of Oral XG005 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 06 Mar 2018
Price : $35 *
At a glance
- Drugs Naproxen/pregabalin (Primary) ; Naproxen sodium; Pregabalin
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Xgene Pharmaceutical
- 02 Mar 2018 Status changed from recruiting to completed.
- 15 Nov 2017 Status changed from not yet recruiting to recruiting.
- 15 Nov 2017 Planned number of patients changed from 40 to 50.